Intech Biopharm Corporation (TPEX:6461)
Taiwan · Delayed Price · Currency is TWD 17.75
-0.10 (-0.56%)
Oct 9, 2025, 1:22 PM CST
Intech Biopharm Company Description
Intech Biopharm Corporation engages in developing and manufacturing generic drugs to treat respiratory diseases in Taiwan and internationally.
It owns iLEF (inhaled low ethanol formulation), a metered dose inhaler platform for treating asthma and COPD; and dry powder inhaler, a product comprises of blisters and capsules.
The company offers its products under the SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011 names.
Intech Biopharm Corporation was founded in 2010 and is headquartered in Taipei, Taiwan.
Intech Biopharm Corporation
| Country | Taiwan |
| Founded | 2010 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 90 |
| CEO | Manish Chawla |
Contact Details
Address: No. 36, Ruiguang Road Taipei, 114 Taiwan | |
| Phone | 886 2 7721 8877 |
| Website | intechbiopharm.com |
Stock Details
| Ticker Symbol | 6461 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006461007 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Chien-Yiu Yang | Finance Division Head |
| Dr. Manish Chawla | President and Chief Scientific Officer |